The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides
Open accessAbstract
Remnants of triglyceride-rich lipoproteins (TRL) have been implicated in the early development of atherosclerosis. We tested this hypothesis by quantifying the plasma concentration of remnant-like particle cholesterol (RLP-C) in a cohort of healthy 50-year-old men in whom the common carotid artery intima-media thickness (CCA-IMT) was assessed by B-mode ultrasound as a surrogate marker for atherosclerosis. The subjects were given a fat-rich meal to study the generation of RLP-C during postprandial lipemia. Fasting plasma RLP-C and other major fasting plasma lipids and lipoproteins were determined twice, and the mean RLP-C concentration was strongly correlated with CCA-IMT (r = 0.32, P = 0.002). In addition, low density lipoprotein (LDL) cholesterol (r = 0.25, P = 0.01) and plasma triglycerides (r = 0.20, P = 0.05) were significantly related to CCA-IMT. Multivariate analyses showed a triglyceride-independent contribution of RLP-C to CCA-IMT. After fat intake, the median plasma RLP-C concentration was doubled after 3 h. The increase was strongly related to the postprandial generation of TRL apolipoprotein (apo)B-48, and large (S(f) 60;-400) TRL apoB-100. The association with CCA-IMT was somewhat stronger for the 3-h RLP-C level than for the fasting RLP-C concentration [r = 0.27, P < 0.01 (3 h) compared with r = 0.22, P < 0.05 (0 h)]. We conclude that the plasma concentration of RLP-C is related to CCA-IMT, independent of plasma triglycerides and LDL cholesterol, in a healthy middle-aged male population. - Karpe, F., S. Boquist, R. Tang, G. M. Bond, U. de Faire, and A. Hamsten. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J. Lipid Res. 2001. 42: 17;-21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, elevated levels of cholesterol-enriched remnant lipoproteins contribute to the development of premature coronary [22,23,24] and peripheral [25,26] atherosclerosis.”
From Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carlson, K. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.32 · Cited by 420
Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417
Phillips, A. N., & Smith, G. D. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90155-3 · Cited by 275
Boquist, S., Ruotolo, G., Tang, R., Björkegren, J., Bond, M. G., Fairé, U. D., Karpe, F., & Hamsten, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.723 · Cited by 258
Self-citationCampos, E. M., Nakajima, K., Tanaka, A., & Havel, R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41527-5 · Cited by 185
Karpe, F., & Hamsten, A. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39974-0 · Cited by 182
Self-citationKarpe, F., Fairé, U. D., Mercuri, M. F., BOND, M., Hellénius, M.-L., & Hamsten, A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00184-1 · Cited by 110
Self-citationKarpe, F., Hellénius, M.-L., & Hamsten, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90076-8 · Cited by 97
Self-citationTriglycerides are more important in atherosclerosis than epidemiology has suggested
Durrington, P. N. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00219-6 · Cited by 72
Björkegren, J., Boquist, S., Samnegård, A., Lundman, P., Tornvall, P., Ericsson, C.-G., & Hamsten, A. (2000) · Circulation · doi:10.1161/01.cir.101.3.227 · Cited by 70
Self-citation
Research works printed but not linked: 1
- Nakajima, 1996, Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B and apo A-I, J. Clin. Ligand Assay, 19, 177
Cited by
Sorted by citations
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115
Lipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 326
Haidari, M., Leung, N., Mahbub, F., Uffelman, K., Kohen-Avramoglu, R., Lewis, G., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200544200 · Cited by 191
Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251
Nakajima, K., Nakano, T., & Tanaka, A. (2006) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2005.12.013 · Cited by 205
Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201
Kaysen, G. A., & Eiserich, J. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000111744.00916.e6 · Cited by 185
Postprandial hypertriglyceridemia as a coronary risk factor
Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182
Pfeuffer, M., Auinger, A., Bley, U., Kraus-Stojanowic, I., Laue, C., Winkler, P., Rüfer, C. E., Frank, J., Boesch‐Saadatmandi, C., Rimbach, G. H., et al. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.08.010 · Cited by 182
Joshi, P. H., Khokhar, A. A., Massaro, J. M., Lirette, S. T., Griswold, M. E., Martin, S. S., Blaha, M. J., Kulkarni, K. R., Correa, A., D'Agostino, R. B., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002765 · Cited by 177
Postprandial lipoprotein metabolism: VLDL vs chylomicrons
Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.018 · Cited by 179
Lichtenstein, A. H. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.07.005 · Cited by 147
Remnant Lipoproteins As Strong Key Particles to Atherogenesis
Fujioka, Y., & Ishikawa, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e598 · Cited by 146
Ezetimibe: cholesterol lowering and beyond
Bays, H. E., Neff, D., Tomassini, J. E., & Tershakovec, A. M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.4.447 · Cited by 147
Postprandial Hyperlipidemia and Remnant Lipoproteins
Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
Tan, G. D., Fielding, B. A., Currie, J. M., Humphreys, S. M., D�sage, M., Frayn, K. N., Laville, M., Vidal, H., & Karpe, F. (2004) · Diabetologia · doi:10.1007/s00125-004-1619-9 · Cited by 119
Self-citationPostprandial lipemia as a cardiometabolic risk factor
Pirillo, A., Norata, G. D., & Catapano, A. L. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.909394 · Cited by 108
Qin, B., Qiu, W., Avramoglu, R. K., & Adeli, K. (2007) · Diabetes · doi:10.2337/db06-0518 · Cited by 103
Lewis, G. F., Uffelman, K. D., Naples, M., Szeto, L., Haidari, M., & Adeli, K. (2004) · Endocrinology · doi:10.1210/en.2004-1143 · Cited by 99
Apolipoprotein CIII links dyslipidemia with atherosclerosis
Kawakami, A., & Yoshida, M. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e607 · Cited by 98
Non-HDL Cholesterol as a Measure of Atherosclerotic Risk
Packard, C. J., & Saitō, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.6 · Cited by 95
Are the health benefits of fish oils limited by products of oxidation?
Turner, R., McLean, C. H., & Silvers, K. M. (2006) · Nutrition Research Reviews · doi:10.1079/nrr2006117 · Cited by 94
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia
Reaven, G. M. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1462-8902.2001.00037.x · Cited by 92
Recent insights into factors affecting remnant lipoprotein uptake
Williams, K. J., & Chen, K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338cabc · Cited by 91
Are Remnant-Like Particles Independent Predictors of Coronary Heart Disease Incidence?
Imke, C., Rodríguez, B. L., Grove, J., McNamara, J. R., Waslien, C., Katz, A. R., Willcox, B. J., Yano, K., & Curb, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000173310.85845.7b · Cited by 89
Koga, H., Sugiyama, S., Kugiyama, K., Fukushima, H., Watanabe, K., Sakamoto, T., Yoshimura, M., Jinnouchi, H., & Ogawa, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi746 · Cited by 90
Koutsari, C., Karpe, F., Humphreys, S. M., Frayn, K. N., & Hardman, A. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095553 · Cited by 79
Self-citationHomma, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.265 · Cited by 52
Remnant lipoproteins and atherosclerosis
Twickler, T., Dallinga-Thie, G., Chapman, M. J., & Cohn, J. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0037-x · Cited by 74
Nakajima, K., Nagamine, T., Fujita, M., Ai, M., Tanaka, A., & Schaefer, E. J. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800263-6.00003-3 · Cited by 72
Lipaemia, Inflammation and Atherosclerosis
van Oostrom, A. J. H. H. M., van Wijk, J. P. H., & Cabezas, M. C. (2004) · Drugs · doi:10.2165/00003495-200464002-00004 · Cited by 67
MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
Solly, E. L., Dimasi, C. G., Bursill, C. A., Psaltis, P. J., & Tan, J. T. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122199 · Cited by 68
Heritability of carotid intima-media thickness: A twin study
Zhao, J., Cheema, F. A., Bremner, J. D., Goldberg, J. H., Su, S., Snieder, H., Maisano, C., Jones, L. R., Javed, F., Murrah, N. V., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.030 · Cited by 63
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis
Nakajima, K., & Tanaka, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.039 · Cited by 54
Chen, K., Liu, M., Schaffer, L., Li, M., Boden, G. H., Wu, X., & Williams, K. J. (2010) · Hepatology · doi:10.1002/hep.23916 · Cited by 58
Lewis, G. F., Naples, M., Uffelman, K. D., Leung, N. M., Szeto, L., & Adeli, K. (2004) · Endocrinology · doi:10.1210/en.2003-1559 · Cited by 56
The close relationship between postprandial remnant metabolism and insulin resistance.
Funada, J., Sekiya, M., Otani, T., Watanabe, K., Sato, M., & Akutsu, H. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.09.016 · Cited by 53
Toth, P. P., Fazio, S., Wong, N. D., HULL, M. L., & Nichols, G. A. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13921 · Cited by 59
Blackburn, P., Lamarche, B., Couillard, C., Pascot, A., Tremblay, A., Bergeron, J., Lemieux, I., & Després, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3303 · Cited by 52
Granér, M., Kahri, J., Varpula, M., Salonen, R. M., Nyyssönen, K., Jauhiainen, M., Nieminen, M. S., Syvänne, M., & Taskinen, M.-R. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.003 · Cited by 53
Remnant lipoproteins and atherogenesis.
Kawakami, A., Yoshida, M., Tanaka, A., Nakajima, K., Yasukochi, Y., Shimokado, K., & Numano, F. (2001) · Annals of the New York Academy of Sciences · doi:10.5551/jat.12.73 · Cited by 28
Postprandial lipemia—effect of lipid-lowering drugs
Karpe, F. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00004-6 · Cited by 50
Self-citationPostprandial Lipemia in Hypertension
Kolovou, G. D., Daskalova, D. C., Iraklianou, S. A., Adamopoulou, E. N., Pilatis, N. D., Hatzigeorgiou, G., & Cokkinos, D. V. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719279 · Cited by 48
Gill, J., Al-Mamari, A., Ferrell, W., Cleland, S., Sattar, N., Packard, C., Petrie, J., & Caslake, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.009 · Cited by 51
Levy, E. H., Spahis, S., Ziv, E., Marette, A., Elchebly, M., Lambert, M. A., & DELVIN, E. E. (2006) · Diabetologia · doi:10.1007/s00125-006-0315-3 · Cited by 52
Ohira, M., Endo, K., Oyama, T., Yamaguchi, T., Ban, N., Kawana, H., Nagayama, D., Nagumo, A., Saiki, A., Murano, T., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.001 · Cited by 47
Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.
Higgins, V., & Adeli, K. (2017) · PubMed Central · Cited by 47
The impact of triglycerides on glucose tolerance: Lipotoxicity revisited
Seghieri, M., Tricò, D., & Natali, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.04.010 · Cited by 42
Makino, A., Ishii, K., Murate, M., Hayakawa, T., Suzuki, Y., Suzuki, M., Ito, K., Fujisawa, T., Matsuo, H., Ishitsuka, R., et al. (2006) · Biochemistry · doi:10.1021/bi052104y · Cited by 43
Perona, J. S., & Ruíz-Gutiérrez, V. (2004) · Journal of Separation Science · doi:10.1002/jssc.200301723 · Cited by 42
n−3 long‐chain FA decrease serum levels of TG and remnant‐like particle‐cholesterol in humans
Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Watanabe, S., Hamazaki, T., Sawazaki, S., TERASAWA, K., Nakajima, S., Terano, T., et al. (2003) · Lipids · doi:10.1007/s11745-003-1069-x · Cited by 41
Tan, K. C. B., Tso, A. W. K., Tam, S., Pang, R. W. C., & Lam, K. S. L. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00823.x · Cited by 41
Kim, J.-Y., Park, J.-H., Jeong, S.-W., Schellingerhout, D., Park, J., Lee, D.-K., Choi, W. J., Chae, S., & Kim, D.-E. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.4.203 · Cited by 35
Izumida, T., Nakamura, Y., Hino, Y., & Ishikawa, S. (2020) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.49528 · Cited by 37
Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice
Alipour, A., Valdivielso, P., Elte, J. W. F., Janssen, H. W., Rioja, J., van der Meulen, N., van Mechelen, R., Njo, T. L., González‐Santos, P., Rietveld, A. P., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02635.x · Cited by 40
Triglycerides: risk factor or fellow traveler?
Forrester, J. S. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200107000-00007 · Cited by 40
Liu, D., Wang, S.-L., Li, J., Liang, E., Yan, M.-Z., & Gao, W. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4698 · Cited by 39
Effects of diacylglycerol ingestion on postprandial hyperlipidemia in diabetes
Tada, N., Shoji, K., Takeshita, M., Watanabe, H., Yoshida, H., Hase, T., Matsuo, N., & Tokimitsu, I. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.10.006 · Cited by 39
Gavin, C., Sigal, R., Cousins, M., Menard, M., Atkinson, M., Khandwala, F., Kenny, G., Proctor, S., & Ooi, T. C. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.071 · Cited by 33
The role of diet and nutritional supplements in preventing and treating cardiovascular disease
Hill, A. M., Fleming, J. A., & Kris‐Etherton, P. M. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832f2fb1 · Cited by 39
Granér, M., Kahri, J., Nakano, T., Sarna, S. J., Nieminen, M. S., Syvänne, M., & Taskinen, M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01720.x · Cited by 35
Baldassarre, D., Amato, M., Eligini, S., Barbieri, S. S., Mussoni, L., Frigerio, B., Kozàkovà, M., Tremoli, E., Sirtori, C. R., & Colli, S. (2006) · Annals of Medicine · doi:10.1080/07853890600852880 · Cited by 34
Ryan, J. J., Hanes, D. A., Schafer, M., Mikolai, J., & Zwickey, H. L. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0063 · Cited by 34
Twickler, T., Dallinga-Thie, G., Visseren, F., de Vries, W. D., Erkelens, D., & Koppeschaar, H. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2002-020470 · Cited by 33
Holmer-Jensen, J., Hartvigsen, M. L., Mortensen, L. S., Astrup, A. V., de Vrese, M., Holst, J. J., Thomsen, C. E., & Hermansen, K. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.142 · Cited by 31
Nolting, P. R. W. D. S., Twickler, M., Dallinga‐Thie, G. M., Buirma, R. J. A., Hutten, B. A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000025586.89221.4b · Cited by 31
Hiki, M., Shimada, K., Ohmura, H., Kiyanagi, T., Kume, A., Sumiyoshi, K., Fukao, K., Inoue, N., Mokuno, H., Miyazaki, T., et al. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.09.010 · Cited by 30
Yamazaki, M., Uchiyama, S., Xiong, Y., Nakano, T., Nakamura, T., & Iwata, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.029 · Cited by 30
Modifying the Sugar Moieties of Daunorubicin Overcomes P-gp-Mediated Multidrug Resistance
Battisti, R. F., Zhong, Y., Fang, L., Gibbs, S. T., Shen, J., Nadas, J., Zhang, G., & Sun, D. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060075v · Cited by 29
Lundahl, B., Hamsten, A., & Karpe, F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.102876 · Cited by 29
Self-citationHigh Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia
Graaf, J. D., van der Vleuten, G. M., ter Avest, E., Dallinga‐Thie, G. M., & Stalenhoef, A. F. H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1973 · Cited by 26
Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders
López-Pedrera, C., Barbarroja, N., Patiño-Trives, A. M., Luque-Tévar, M., Torres-Granados, C., Aguirre, M. A., Collantes‐Estévez, E., & Pérez‐Sánchez, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062012 · Cited by 28
Masuda, D., Kobayashi, T., Sairyou, M., Hanada, H., Ohama, T., Koseki, M., Nishida, M., Maeda, N., Kihara, S., Minami, T., et al. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.41343 · Cited by 27
Wu, B., Huang, J., Fukuo, K., Suzuki, K., Yoshino, G., & Kazumi, T. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1289485 · Cited by 26
Beer, S., Moren, X., Ruiz, J. C., & James, R. W. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.09.005 · Cited by 26
Twickler, T. B., Dallinga‐Thie, G. M., ZELISSEN, P. M. J., Koppeschaar, H. P. F., & Erkelens, D. W. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01326.x · Cited by 26
Twickler, T., Cramer, M., Dallinga-Thie, G., Chapman, M., Erkelens, D., & Koppeschaar, H. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2003-030278 · Cited by 30
Ossewaarde, M. E., Dallinga‐Thie, G. M., Bots, M. L., van der Schouw, Y. T., Rabelink, T. J., Grobbee, D. E., & Westerveld, H. T. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01163.x · Cited by 26
Kasahara, A., Adachi, H., Hirai, Y., Enomoto, M., Fukami, A., YOSHIKAWA, K., Esaki, E., Yokoi, K., Ogata, K., Tsukagawa, E., et al. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt011 · Cited by 25
Effect of low concentration of diacylglycerol on mildly postprandial hypertriglyceridemia
Saito, S., Yamaguchi, T. F., Shoji, K., Hibi, M., Sugita, T., & Takase, H. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.062 · Cited by 25
Ai, M., Tanaka, A., Shoji, K., Ogita, K., Hase, T., Tokimitsu, I., & Shimokado, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.034 · Cited by 25
Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles
Schlitt, A., Hojjati, M. R., von Gizycki, H., Lackner, K. J., Blankenberg, S., Schwaab, B., Meyer, J., Rupprecht, H. J., & Jiang, X. (2004) · Journal of Lipid Research · doi:10.1194/jlr.c400011-jlr200 · Cited by 25
Epidemiology of Macrovascular Disease and Hypertension in Diabetes Mellitus
Tuomilehto, J. O., Rastenytė, D., Qiao, Q., & Jakovljević, D. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1002 · Cited by 25
Remnant Lipoproteins: Measurement and Clinical Significance
Jialal, I., & Devaraj, S. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.217 · Cited by 24
Johanson, E. H., Jansson, P., Gustafson, B., Lönn, L., Smith, U., Taskinen, M., & Axelsen, M. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01281.x · Cited by 22
Fonseca, M. I. H., de Almeida-Pititto, B., Benseñor, I. M., Toth, P. P., Jones, S. R., Blaha, M. J., Lotufo, P. A., Kulkarni, K. R., & Ferreira, S. R. G. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.09.005 · Cited by 20
Alssema, M., Schindhelm, R. K., Dekker, J. M., Diamant, M., Kostense, P. J., Teerlink, T., Scheffer, P. G., Nijpels, G., & Heine, R. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.021 · Cited by 20
Postprandial dyslipidemia in insulin resistant states in adolescent populations
Higgins, V., & Adeli, K. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190094 · Cited by 20
Bruemmer, D., & Cho, L. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.121.012615 · Cited by 18
Yoshida, H., Kurosawa, H., Hirowatari, Y., Ogura, Y., Ikewaki, K., Abe, I., Saikawa, S., Domitsu, K., Ito, K., Yanai, H., et al. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-18 · Cited by 19
Insulin resistance and vessel endothelial function.
van Oostrom, A. J. H. H. M., Cabezas, M. C., & Rabelink, T. J. (2002) · Europe PMC (PubMed Central) · Cited by 18
Tzou, W. S., Douglas, P. S., Srinivasan, S. R., Chen, W., Berenson, G. S., & Stein, J. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-9-200505030-00009 · Cited by 18
Xu, X., Pandit, R. U., Han, L., Li, Y., & Guo, X. (2019) · Angiology · doi:10.1177/0003319719854296 · Cited by 17
Hepatic Syndecan-1 Changes Associate With Dyslipidemia After Renal Transplantation
Adepu, S., Katta, K., Tietge, U. J. F., Kwakernaak, A. J., Dam, W., van Goor, H., Dullaart, R. P. F., Navis, G. J., Bakker, S. J. L., & van den Born, J. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12842 · Cited by 17
Zhang, B., Böttcher, A., Imaizumi, S., Noda, K., Schmitz, G., & Saku, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.004 · Cited by 16
Zhang, B., Maeda, N., Okada, K., Tatsukawa, M., Sawayama, Y., Matsunaga, A., Kumagai, K., Miura, S., Nagao, T., Hayashi, J., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.005 · Cited by 16
Kakuda, H., Kobayashi, J., Nakato, M., & Takekoshi, N. (2013) · Cholesterol · doi:10.1155/2013/314170 · Cited by 15
Abdominal and gluteofemoral fat depots show opposing associations with postprandial lipemia
Christiansen, M. R., García‐Ureña, M., Borisevich, D., Grarup, N., Martínez, J. A., Oppert, J., Sørensen, T. I. A., Hansen, T. F., Blaak, E. E., & Kilpeläinen, T. O. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab219 · Cited by 15
van Hees, A. M. J., Saris, W. H. M., Dallinga‐Thie, G. M., Hul, G. B. J., Martínez, J. A., Oppert, J., Štich, V., Astrup, A. V., Arner, P., Sørensen, T. I. A., et al. (2008) · Journal of Nutrition · doi:10.3945/jn.108.094516 · Cited by 15
Chiu, C.-H., Burns, S., Yang, T.-J., Chang, Y. H., Chen, Y.-L., Chang, C.-K., & Wu, C.-L. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-177 · Cited by 12
Metadata
- Authors
- Karpe, F., Boquist, S., Tang, R., Bond, G. M., de Faire, U., & Hamsten, A.
- Affiliations
- Karolinska Institutet (SE)
- Wake Forest University Health Sciences (US)
- Corresponding author
- Karpe, Fredrik
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 42
- Issue
- 1
- Pages
- 17-21
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W1936800019
- Cited by
- 174
- References
- 14
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 4 · 2012: 6
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- remnant-like particle cholesterol, remnant lipoproteins, triglyceride-rich lipoproteins, carotid intima-media thickness, atherosclerosis, LDL cholesterol, plasma triglycerides, postprandial lipemia, apolipoprotein B-48, apolipoprotein B-100, high-fat meal, middle-aged men
- MeSH terms
- Apolipoproteins, Arteriosclerosis, Carotid Arteries, Cholesterol, Fasting, Humans, Lipoproteins, Cholesterol, LDL, Male, Middle Aged, Triglycerides, Ultrasonography, Cohort Studies, Linear Models, Tunica Intima
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review